K. Schmiegelow

K. Schmiegelow

Clinical Professor

Member of:

  • Paediatrics


Publication year:
All
1 - 10 out of 378Page size: 10
Sort by: 1st author
  1. Published

    Intermittent Versus Continuous PEG-Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study

    Albertsen, B. K., Grell, Kathrine, Abrahamsson, J., Lund, B., Vettenranta, K., Jónsson, Ó. G., Frandsen, T. L., Wolthers, B. O., Heyman, M. & Schmiegelow, Kjeld, 2019, In: Journal of Clinical Oncology. 37, 9, p. 1638-1646 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Asparaginase encapsulated in erythrocytes as second-line treatment in hypersensitive patients with acute lymphoblastic leukaemia

    Albertsen, B. K., Lynggaard, L. S. & Schmiegelow, Kjeld, 2022, In: British Journal of Haematology. 198, 6, p. e84-e85

    Research output: Contribution to journal › Letter › Research › peer-review

  3. Published

    Classification of treatment-related mortality in children with cancer: a systematic assessment

    Alexander, S., Pole, J. D., Gibson, P., Lee, M., Hesser, T., Chi, S. N., Dvorak, C. C., Fisher, B., Hasle, H., Kanerva, J., Möricke, A., Phillips, B., Raetz, E., Rodriguez-Galindo, C., Samarasinghe, S., Schmiegelow, Kjeld, Tissing, W., Lehrnbecher, T., Sung, L. & International Pediatric Oncology Mortality Classification Group, I. P. O. M. C. G., Dec 2015, In: Lancet Oncology. 16, 16, p. e604-10 7 p.

    Research output: Contribution to journal › Review › Research › peer-review

  4. Published

    Acute central nervous system toxicity during treatment of pediatric acute lymphoblastic leukemia: phenotypes, risk factors and genotypes

    Anastasopoulou, S., Nielsen, R. L., Als-Nielsen, B., Banerjee, J., Eriksson, M. A., Helenius, M., Heyman, M. M., Johannsdottir, I. M., Jonsson, O. G., MacGregor, S., Mateos, M. K., Mayoh, C., Mikkel, S., Myrberg, I. H., Niinimäki, R., Schmiegelow, K., Taskinen, M., Vaitkeviciene, G., Warnqvist, A., Wolthers, B. & 2 others, Harila-Saari, A. & Ranta, S., 2022, In: Haematologica. 107, 10, p. 2318-2328 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Does minimal central nervous system involvement in childhood acute lymphoblastic leukemia increase the risk for central nervous system toxicity?

    Anastasopoulou, S., Harila-Saari, A., Als-Nielsen, B., Eriksson, M. A., Heyman, M., Johannsdottir, I. M., Marquart, Hanne Vibeke Hansen, Niinimäki, R., Pronk, C. J., Schmiegelow, Kjeld, Vaitkeviciene, G., Thastrup, M. & Ranta, S., 2022, In: Pediatric Blood and Cancer. 69, 7, e29745.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia: Clinical characteristics, risk factors, course, and outcome of disease

    Anastasopoulou, S., Eriksson, M. A., Heyman, M., Wang, C., Niinimäki, R., Mikkel, S., Vaitkevičienė, G. E., Johannsdottir, I. M., Myrberg, I. H., Jonsson, O. G., Als-Nielsen, B., Schmiegelow, Kjeld, Banerjee, J., Harila-Saari, A. & Ranta, S., 2019, In: Pediatric Blood & Cancer. 66, 5, e27594.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Seizures during treatment of childhood acute lymphoblastic leukemia: A population-based cohort study

    Anastasopoulou, S., Heyman, M., Eriksson, M. A., Niinimäki, R., Taskinen, M., Mikkel, S., Vaitkeviciene, G. E., Johannsdottir, I. M., Myrberg, I. H., Jonsson, O. G., Als-Nielsen, B., Schmiegelow, Kjeld, Banerjee, J., Ranta, S. & Harila-Saari, A., 2020, In: European Journal of Paediatric Neurology. 27, p. 72-77

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Characterization of t(12;21) breakpoint junctions in acute lymphoblastic leukemia [3]

    Andersen, M. T., Nordentoft, I., Hjalgrim, L. L., Christiansen, C. L., Jakobsen, V. D., Hjalgrim, Henrik, Pallisgaard, N., Madsen, H. O., Christiansen, M., Ryder, L. P., Clausen, N., Hokland, P., Schmiegelow, Kjeld, Melbye, M. & Jørgensen, P., 2001, In: Leukemia. 15, 5, p. 858-859 2 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  9. Published

    Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia: A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma

    Andersen, M. A., Valentin, R., Sjö, Lene Dissing, Borgwardt, L., Schmiegelow, Kjeld, Andersen, M. K., Marvig, R. L., Yde, C. W. & Niemann, Carsten, 2020, In: Acta Oncologica. 59, 12, p. 1547-1551

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  10. Published

    Patterns of exposure to infectious diseases and social contacts in early life and risk of brain tumours in children and adolescents: an International Case–Control Study (CEFALO)

    Andersen, T. V., Schmidt, L. S., Poulsen, A. H., Feychting, M., Röösli, M., Tynes, T., Aydin, D., Prochazka, M., Lannering, B., Klæboe, L., Eggen, T., Kuehni, C. E., Schmiegelow, Kjeld & Schüz, J., 2013, In: B J C. 108, 11, p. 2346-2353 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...38 Next

ID: 8780